Delay of therapy was defined as a gap in treatment exceeding twice the NCCN specified cycle length specific to each chemotherapy regimen Table 2 low dose tamoxifen RNA quality was audited using an Agilent Bioanalyzer and the RNA Nano Chip Kit Agilent Technologies
